Wenyong Wu Selected Research

Wenyong Wu Research Topics

Disease

13	Neoplasms (Cancer) 01/2024 - 01/2012
5	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 02/2012
3	Hypertension (High Blood Pressure) 01/2022 - 03/2020
2	Cachexia 03/2024 - 12/2023
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2023
2	Stomach Neoplasms (Stomach Cancer) 06/2022 - 08/2014
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
1	Precocious Puberty 04/2023
1	Atrophy 03/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Central Nervous System Diseases (CNS Diseases) 07/2022
1	Bites and Stings (Sting) 01/2022
1	Myocardial Infarction 09/2021
1	Inflammation (Inflammations) 09/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2020
1	Ischemia 08/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2020
1	Alzheimer Disease (Alzheimer's Disease) 03/2020
1	Convalescence 01/2020
1	Ischemic Stroke 01/2020
1	Callosities 04/2019
1	Bacteremia 01/2014
1	Pneumonia (Pneumonitis) 01/2014
1	Leukocytosis (Pleocytosis) 01/2014
1	Leukopenia 01/2014
1	Crohn Disease (Crohn's Disease) 01/2013

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2012
4	AcidsIBA 01/2022 - 08/2020
3	shenqi fuzhengIBA 03/2024 - 03/2023
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2012
3	EnzymesIBA 01/2022 - 01/2014
2	LipidsIBA 01/2023 - 08/2020
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 09/2021
2	TabletsIBA 09/2021 - 08/2020
2	danqi tongmaiIBA 09/2021 - 08/2020
2	AntigensIBA 08/2014 - 01/2013
1	GlucocorticoidsIBA 03/2024
1	Tricarboxylic AcidsIBA 12/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2023
1	Huang QiIBA 03/2023
1	CytokinesIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	BufanolidesIBA 01/2023
1	phospholipase D1IBA 01/2023
1	chan su (ChanSu)IBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Secologanin Tryptamine Alkaloids (Alseroxylon)FDA Link 07/2022
1	TriterpenesIBA 06/2022
1	inonotsuoxide BIBA 06/2022
1	atezolizumabIBA 01/2022
1	ElonginIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Epoxide HydrolasesIBA 01/2022
1	InterferonsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Linoleic Acid (Linoleate)IBA 01/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	OxylipinsIBA 09/2021
1	amsonic acid (DAS)IBA 08/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2021
1	Becaplermin (PDGF-BB)FDA Link 11/2020
1	Ion Channels (Ion Channel)IBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 08/2020
1	AlkaloidsIBA 03/2020
1	Antihypertensive Agents (Antihypertensives)IBA 03/2020
1	Ginkgo biloba extract (Rokan)IBA 01/2020
1	Heavy MetalsIBA 04/2019
1	LigandsIBA 01/2018
1	Hormones (Hormone)IBA 05/2016
1	Human Growth Hormone (Saizen)FDA LinkGeneric 05/2016
1	ProlactinIBA 05/2016
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 08/2014
1	Carcinoembryonic AntigenIBA 08/2014
1	CarbohydratesIBA 08/2014
1	Tumor Biomarkers (Tumor Markers)IBA 08/2014
1	Virulence Factors (Pathogenicity Factors)IBA 01/2014
1	Peptide Elongation Factor Tu (EF-Tu)IBA 01/2014
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 02/2012
1	Blood Proteins (Serum Proteins)IBA 02/2012
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Fibronectins (Fibronectin)IBA 01/2012
1	Cadherins (E-Cadherin)IBA 01/2012
1	VimentinIBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	matrigelIBA 01/2012

Therapy/Procedure

4	Immunotherapy 01/2023 - 01/2022
4	Therapeutics 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 03/2024 - 12/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Length of Stay 01/2014